Aletta Ann Frazier, MD

The impact of simultaneous pancreaskidney transplantation on longterm patient survival antimicrobial watches buy discount arzomicin on-line. Periconception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with preexisting diabetes: a populationbased cohort study antibiotic mnemonics order 250 mg arzomicin fast delivery. Influence of pregnancy on progression of diabetic nephropathy and subsequent requirement of renal replacement therapy in female type I diabetic patients with impaired renal function antibiotic resistance and factory farming buy cheap arzomicin line. His general practitioner noticed that his renal function has been slowly declining over the years and suspects diabetic nephropathy antibiotics for acne in pregnancy cheap arzomicin online visa. Screen and treat for retinopathy and coronary artery disease prior to conception 230 Diabetic Nephropathy Answers 1 antibiotic resistance hospital acquired infections purchase 500 mg arzomicin overnight delivery. Strict arterial blood pressure control has proven to be one of the most important factors in preventing or delaying progression of diabetic nephropathy, and other cardiovascular complications. Studies support the recommendation that all patients with diabetes should be treated for hypertension with a target blood pressure of less than 140/90 mmHg. In patients with coexisting microalbuminuria, a more intensive blood pressure target of 130/80 is supported by some additional studies. It is likely that the specific benefits of these drugs relate to their ability to alter intraglomerular pressure, owing to the role of angiotensin in causing efferent arteriolar vasoconstriction. If a patient with diabetes experiences a sudden deterioration in renal function, it is unlikely to be due to diabetic nephropathy alone. All patients with diabetes should be screened on a regular basis for evidence of early diabetic nephropathy so that interventions may be undertaken to prevent or delay its progression. Sulphonylureas can be used but run a higher risk of causing hypoglycaemia given the reduced renal clearance. Blood glucose control is a strong predictor of the risk of diabetic nephropathy, though there is significant intraindividual variation. Smoking habits, and the amount and origin of dietary protein also seem to play a role as risk factors. It is vital to strictly control blood glucose levels and blood pressure during pregnancy to reduce maternal and foetal complications. Choice of antihypertensive medication use in pregnancy is limited due to potential for teratogenicity. Phanish and Vinay Sakhuja Summary · Plasma cell dyscrasias are a heterogenous group of disorders characterized by the proliferation of monoclonal bone marrow plasma cells. Clinical manifestations can range from relatively benign presentation with an incidental discovery of paraprotein to an aggressive malignant disease. These diseases are often associated with kidney disease, and advanced kidney disease can limit treatment options, making early diagnosis and treatment an essential aspect of care given to these patients. Light chains, by virtue of their smaller size, are freely filtered across the glomeruli and hence cause nephrotoxicity, as discussed later. The plasma cells proliferate in the bone marrow and can cause extensive skeletal damage. Up to 10% of patients present in severe renal failure needing dialysis and only 15­30% of these patients can discontinue dialysis. Myeloma accounts for around 13% of all haematological cancers and is characterized by dysregulated overproduction of immunoglobulins by a single clone of malignant plasma cells. Paraproteins produced are immunoglobulin (Ig) G in 52%, IgA in 21%, kappa or lambda light chain only (Bence­Jones protein) in 16%, IgD in 2%, biclonal in 2%, IgM in 0. Evidence of endorgan damage that can be attributed to the underlying plasma cell proliferative disorder, specifically: · Hypercalcaemia: serum calcium >0. These tubular casts occlude the tubular lumen, leading to cast nephropathy (myeloma kidney) and the resultant renal failure. The greater the urinary excretion of free light chains, the greater is the risk for renal failure. The obstructing casts elicit a surrounding interstitial inflammatory reaction with or without multinucleated giant cells and at times lead to tubular rupture, allowing escape of the light chains into the interstitium and leading to an interstitial inflammatory process. The amount of filtered free light chains (light chain load) is a critical factor for the development of cast nephropathy. Excessive monoclonal light chains freely filtered by the glomerulus lead to intratubular cast formation and elicit an inflammatory reaction. The risk of renal failure is twice as high in patients with pure light chain myeloma. More than 70% of patients who secrete >10 g/day of light chains develop renal failure [5]. Whilst both kappa and lambda light chains can cause renal injury, some Volume depletion, by slowing down the flow within the tubules, which can promote cast formation. Metabolic acidosis, which by lowering the urinary pH promotes the binding of free light chains to Tamm­Horsfall protein. Radiocontrast agents, which may interact with light chains and promote intratubular obstruction. It is important to note that light chains in urine are not detected by urinary dipsticks. Interestingly, when light chains from patients with myeloma cast nephropathy are injected into mice, they precipitate in tubules, causing cast nephropathy more frequently when compared to light chains from myeloma patients with normal renal function. This suggests that these light chains causing cast nephropathy are inherently abnormal [6]. Glomeruli are typically spared unless there is associated amyloidosis or light chain deposition disease. Treatment of Myeloma Cast Nephropathy Correction of Reversible Factors these patients often present with significant dehydration and require aggressive hydration with intravenous normal saline. The use of frusemide to promote diuresis should be avoided, as increased distal delivery of sodium (Na+) and acidic urinary pH can increase binding of free light chains to Tamm­Horsfall protein and thus promote tubular cast formation. Alkalinization of urine with intravenous sodium bicarbonate inhibits cast formation by inhibiting the 236 Kidney Disease in Myeloma interaction between the free light chains and Tamm­ Horsfall protein [7]. Reducing the Production of Light Chains Chemotherapy aimed at rapid reduction in the levels of free light chains has resulted in significant improvements in both renal recovery and overall survival [8]. The immediate commencement of highdose dexamethasone is advised, as the plasma cells are highly responsive to corticosteroids. The firstline agent in the current era is bortezomib, which is a potent proteasome inhibitor. In addition to its potent proapoptotic effects on monoclonal Igproducing malignant plasma cells, it is also thought to reduce interstitial inflammation by inhibiting the inflammatory cell signalling cascade triggered by light chain endocytosis in proximal tubules. Due to the latter effect, in clinical practice, improvement in renal function is often seen before the peak effects on plasma cells (which take around 30 days). However, some of the reduction in interstitial inflammation would be attributable to highdose steroids used concomitantly. Other commonly used drugs include thalidomide (and its derivative lenalidomide) and cyclophosphamide. Extracorporeal Therapies to Remove Light Chains Plasmapheresis has been used to remove light chains in an attempt to expedite renal recovery, but its utility in the modern era of bortezomibbased chemotherapy remains unproven. A definitive clinical indication for plasmapheresis would be hyperviscosity syndrome. The high cutoff dialysis leads to increased albumin loss by virtue of the larger pore size of the membrane. Survival of myeloma patients who remain in renal failure is poor, with the reported median survival on dialysis quite dismal [17]. There are infrequent reports of kidney transplantation among patients who are in remission and are free from extrarenal manifestations for more than a year. With regard to dialysis, both haemodialysis and peritoneal dialysis appear to be equally effective. Amyloid Light Chain Amyloidosis Amyloidosis is a disorder characterized by extracellular tissue deposition of fibrils composed of low molecular weight subunits of a variety of proteins, many of which circulate as normal constituents of plasma. The deposition of these fibrils in various organs can lead to different clinical presentations [18]. For reasons which are not yet fully understood, soluble proteins undergo conformational changes leading to the generation of insoluble and rigid fibrillary subunits with a predominantly antiparallel betapleated sheet configuration. The free light chains that are rendered unstable and prone to selfaggregation form protofilaments that associate into amyloid fibrils. These are the common presenting features: Restrictive cardiomyopathy, seen in up to 60% of patients. Hepatomegaly, with or without splenomegaly, in around 70%, with liver function tests showing a cholestatic pattern in up to 25%. The diagnosis requires demonstration of amyloid deposits in the tissue and a plasma cell dyscrasia. When stained with Congo red, the amyloid deposits demonstrate an orangered appearance and applegreen birefringence under polarized light. Evidence that the amyloid is light chainrelated: established by direct examination of the amyloid tissue. These patients often have cardiac involvement and autonomic neuropathy, and are prone to hypotension, fluctuating blood pressure, and cardiac arrhythmias. Sepsis is a common cause of morbidity and mortality, both due to an immunocompromised state from underlying plasma cell dyscrasia and nephrotic syndrome. Monoclonal Immunoglobulin Deposition Disease In this disorder, monoclonal immunoglobulins deposit in the glomeruli, leading to proteinuria and renal insufficiency. The tubules also often show similar deposits along the basement membrane, leading to ribbon like thickening. Kidney transplantation has been performed in these patients, but the recurrence rate is high (around 70%), with the majority of patients losing their grafts due to recurrence within three years [26]. The fibrillary deposits in amyloidosis are Congo red positive, whereas those in fibrillary glomerulonephritis are Congo red negative. Although these disorders do not often fulfil the criteria for a haematological malignancy, they do cause significant renal disease, with poor prognosis and a high rate of recurrence following kidney transplantation. Consequently, initiation of efficient chemotherapy is essential to improve the renal prognosis. Acknowledgement Dr Rajan Duggal, consultant histopathologist, Medanta Hospital, the Medicity, Gurgaon, Haryana, India. Renal function in newly diagnosed multiple myeloma ­ a demographic study of 1353 patients. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Early reduction of serumfree light chains associates with renal recovery in myeloma kidney. Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study. Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Dialysisdependent renal failure in patients with myeloma can be reversed by highdose myeloablative therapy and autotransplant. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cutoff hemodialysis. Longterm outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Prevalence and clinical significance of cryofibrinogenaemia in patients with renal disorders. Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis Interaction of paraprotein with Tamm­ Horsfall protein results in cast formation 3. Which one of the following treatment modalities is likely to be used in a 50yearold patient diagnosed with multiple myeloma Chemotherapy until paraprotein levels drop and plateau, followed by thalidomide maintenance d. High cutoff dialysis to remove free light chains is recommended for all patients with multiple myeloma and cast nephropathy. Intracellular deposition of fragments of abnormal proteins derived from microbes b. Extracellular deposition of fibrils composed of low molecular weight subunits of a variety of proteins, many of which are normal constituents of plasma c. Intravascular deposition of fragments of normal plasma proteins Kidney Disease in Myeloma 243 Answers 1. The casts are formed in the thick ascending limb of loop of Henle and distal tubules as the paraproteins are deposited on the Tamm­ Horsfall protein. Risk factors for myeloma cast nephropathy include dehydration, loop diuretics, metabolic acidosis, and exposure to radiocontrast agents. In those needing dialysis, the use of the expensive high cutoff dialysis does not offer any advantage over conventional dialysis and may lead to increased albumin loss. Renal damage in myeloma is caused by the glomerular filtration of the serum free light chains and therefore a rapid reduction in their number is associated with improved renal prognosis. Amyloidosis is a disorder characterized by extracellular tissue deposition of fibrils composed of low molecular weight subunits of a variety of proteins, many of which circulate as normal constituents of plasma. Secondary tubulointerstitial nephritis signifies inflammation in the setting of primary glomerular or vascular disease [1, 2]. We now know that most glo merular and vascular diseases that lead to a decline in renal function have associated tubulointerstitial nephritis and that the severity of the tubulointerstitial involvement correlates directly with the severity of renal failure [3­5]. The state of the tubulointerstitium appears to play a key role in most renal diseases. Specialized fibroblasts in the inner cortex and outer medulla of the kidney respond to hypoxia by secreting erythropoietin (which explains an anaemia that is out of proportion to the degree of renal dys function in patients with chronic interstitial nephri tis) [8]. A different subset of renal fibroblasts is known Lecture Notes Nephrology: A Comprehensive Guide to Renal Medicine, First Edition. Dendritic cells are also found in large num bers in the interstitium and presumably play a role in the immunological response. In this article, we will limit our discussion to pri mary tubulointerstitial nephritis, in which the glo meruli and vessels are typically uninvolved.

The parasite burden reduction driven in the spleen or in the bone marrow was not statistically significant with this compound antibiotic resistance cases generic 250 mg arzomicin mastercard. Thus virus y antivirus discount 100 mg arzomicin visa, a parasite burden reduction of 95% antibiotics for dogs urinary infection arzomicin 250 mg without prescription, 95% and 99% in spleen antibiotics for dogs buy arzomicin 250 mg order free shipping, liver and bone marrow infection 7 days to die purchase genuine arzomicin on line, respectively, was reached and parasite clearance was achieved in more than half of mice treated. The bone marrow is a relevant target tissue in the progression of visceral leishmaniasis and the parasite elimination is crucial for treatment success. The toxicity study on infected and healthy mice showed that the evolution of weight was similar in infected and untreated animals, without weight loss throughout the experiment. In addition, no signs of pain, stress, diarrhea and death was registered in treated groups, and there were no statistically significant differences in the transaminases, alkaline phosphatase, urea or creatinine values. These results are promising considering that, currently, there are no vaccines that protect against leishmaniasis [68]. Therefore, a potential antileishmanial drug should be effective, safe and affordable. In addition, it has to display high selectivity and potency against the parasite and to be able to be administered by the oral route with a high safety ratio in humans. However, current drugs present high toxicity, adverse effects, resistance, high cost, and geographical variability. In addition, they are expensive and have to be applied over a long period of time, mainly by injection [67, 68]. The transmembrane P-glycoprotein (P-gp) is found in the small intestine, the bloodbrain barrier and the surface of tumor cells. In the intestine, the P-gp can efflux the drug from the basolateral to the apical side of the epithelium. Therefore, the inhibition of P-gp at the intestinal level through carriers with modified surfaces may improve the oral bioavailability of drugs due to enhanced absorption [69]. Chitosan also can be used to alter the surface of drug nanocarriers and allow extended release, while conferring a mucoadhesive nature that enhances drug retention and absorption [71]. In summary, there are several strategies based on the modification of the carrier surface to increase permeability across the intestinal mucosa and therefore improve the absorption and bioavailability [72]. The sample composition and preparation methods of these carriers can influence their behavior in vitro and in vivo. An analogous result was observed for the entrapment efficiency and loading capacity. In vitro release studies showed prolonged release, which lasted for 6 h, with both formulations achieving 80­100%. This organic phase was dropped into aqueous phase with surfactant tetradecyl trimethyl ammonium bromide while homogenizing (12,000 g) during 30 min. Then, this emulsion was magnetically stirred (5 h) at room temperature to evaporate the organic solvent. Particle size, drug encapsulation efficiency, and mean percentage drug release in 24 h were encompassed in the DoE. The criteria of selection was: size <500 nm; drug encapsulation efficiency >56:9% and mean percentage drug release in 24 h >85%. Size was smaller at higher amount of surfactant and intermediate amount of polymer. The optimized formulation contained 278 mg of polymer and 249 mg of emulsifier, and exhibited particle size, drug encapsulation efficiency, and mean percentage drug release in 24 h of 465. In vivo pharmacokinetic assays in Wistar rats showed enhanced bioavailability of the optimized formulation with respect to the pure drug, with an increase of 1. In situ single pass perfusion studies in Wistar rats showed that effective permeability of drug was 2. Rectal route has drawbacks such as limited treatment at the rectum and distal portion of the colon, requires sterile preparation, is undesirable for patients, and therefore, leads to compliance issues. Thus, the development of targeted delivery systems for the oral administration of drugs that can reach a specific portion of the intestine is of great interest [79­81]. Both phases were connected to a microfluidic device, where the collection bath contained 0. In addition, their small size could allow passive accumulation 218 Nanotechnology for oral drug delivery in the inflamed tissue, which is characterized by the loss of the epithelial barrier function and subsequent weakening of the tight junctions, loss of water, and increased permeability of the mucosa. The harsh conditions of the stomach would be the major limiting step for the administration of these oral formulations. At gastric pH, due to the protonation of chitosan amine groups at low pH, cationic chitosan and anionic alginate allow strengthened interpolymeric associations. Therefore, this is a strategy that could be used to encapsulate other protein therapeutics to the small intestine and/or colon after oral administration [82]. The nanogels were lyophilized in the presence of 2% w/v trehalose as cryoprotectant. For example, cells of intestinal epithelium such as M cells, enterocytes or L cells can be targeted with these carriers to improve internalization in the intestinal mucosa. The use of lectin-like receptors to modify the carrier surface can be useful because these receptors bind glycoproteins on M cells and enterocytes. In addition, the use of microbial molecules such as protein invasion or long polar fimbria also can be beneficial because M cells bind pathogen patterns through endocytic pathways. Ligands for these receptors can be peptides (Arg-Gly-Asp and LeuAsp-Val) or peptidomimetics. Other molecules such as vitamin B12, vitamin B1, biotin and folic acid can bind receptors expressed on the enterocyte apical membrane, and can be explored to enhance the therapeutic effect of drug loaded nanoparticles after oral administration. The FcRn, expressed by enterocytes of the intestinal epithelium, can also be targeted to allow for the enhanced delivery of orally administered drug carrier systems. In addition, receptors of bacteria on enterocytes in the intestinal flora could be targeted using Ctx or F4 fimbriae on the surface of the carrier. Finally, L cell receptors such as G-protein-coupled receptors can be useful targets for increased uptake of drugs administered by the oral route [84]. Conclusions the oral route is the most commonly accepted and widely used for drug delivery due to ease of administration, minimal invasiveness and pain, resulting in high levels of compliance and acceptance by patients. However, many drugs are not suitable for administration by this route due to poor solubility, stability, and/or bioavailability. For example, up to 40% of the drugs on the market and 70% of the compounds under development are poorly soluble in water, which limits their absorption and bioavailability. In addition, the ability of the nanocarriers to penetrate quickly through mucus layer covering the intestinal epithelium or to pass through the tight junctions between the epithelial cells has been increasingly investigated. Therefore, the control of the physicochemical properties of the developed nanocarriers, such as size, shape, surface charge and drug release profile is extremely important to ensure therapeutic success after oral administration. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. Insoluble drug delivery strategies: review of recent advances and business prospects. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation. A comparative solubility enhancement study of cefixime trihydrate using different dispersion techniques. Investigation of r´ ´ dissolution mechanism and release kinetics of poorly water-soluble tadalafil from amorphous solid dispersions prepared by various methods. Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles. Formulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain delivery. Preparation and evaluation of diosgenin nanocrystals to improve oral bioavailability. Design of a gelatin microparticle-containing selfmicroemulsifying formulation for enhanced oral bioavailability of dutasteride. Pharmacokinetics of cyclodextrins and drugs after oral and parenteral administration of drug/cyclodextrin complexes. Characterization and in vitro evaluation of the complexes of posaconazole with - and 2,6-di-O-methyl-cyclodextrin. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Mucus permeating carriers: formulation and characterization u of highly densely charged nanoparticles. Development of a virus-mimicking nanocarrier for drug delivery systems: the bio-nanocapsule. Enzyme decorated drug carriers: targeted swords to cleave and overu come the mucus barrier. Improvement of oral bioavailability of lopinavir without co-administration of ritonavir using microspheres of thiolated xyloglucan. Development of phosphoru ylated nanoparticles as zeta potential inverting systems. Zeta-potential-changing nanoparu ticles conjugated with cell-penetrating peptides for enhanced transfection efficiency. Preparation of amphiphilic hollow carbon nanosphere loaded insulin for oral delivery. Biotin-tagged polysaccharide vesicular nanocarriers for receptormediated anticancer drug delivery in cancer cells. Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering. Engineered multifunctional albumindecorated porous silicon nanoparticles for FcRn translocation of insulin. Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape. Bioavailability enhancement of poorly water-soluble drugs via nanocomposites: formulation-processing aspects and challenges. Efficacy and safety profiles of oral atorvastatin-loaded nanoparticles: effect of size modulation on biodistribution. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Development of orally applicable, combinatorial drug-loaded nanoparticles for the treatment of fibrosarcoma. Design, synthesis and evaluation of biotin decorated inulin-based polymeric micelles as long-circulating nanocarriers for targeted drug delivery. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives. Surface phosphorylation of nanoparticles u by hexokinase: a powerful tool for cellular uptake improvement. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers. A nanodelivered Vorinostat derivative is a promising oral compound for the treatment of visceral leishmaniasis. The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. How to design the surface of peptide-loaded ^ nanoparticles for efficient oral bioavailability Progress in developing spray-drying methods for the production of controlled morphology particles: from the nanometer to submicrometer size ranges. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles. Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals. Active targeting of drugs and bioactive molecules via oral administration by ligand-conjugated lipidic nanocarriers: recent advances. Introduction the buccal route has been investigated for decades as an administration site to achieve drug absorption, to reach systemic circulation or to treat local diseases. The interest has dramatically increased in these years because the buccal route has been identified as an alternative to the conventional oral route [1]. Indeed, the buccal route offers several advantages over the conventional drug delivery routes, including the parenteral route. It is characterized by a high blood supply, which ensures systemic bioavailability, avoiding the hepatic first-pass metabolism and the enzymatic drug degradation. In this context, hydrophilic high molecular weight drugs, as peptides or proteins, are favorable candidates [2]. Furthermore, it benefits patient compliance, mainly due to the easily accessibility for the administration by patients, and it is suitable for self-medication both for dosage form administration and its removal [2]. For this reason, it is generally considered in the treatment of chronic disorders when prolonged drug release is required or when the conventional routes do not allow an adequate therapy [3]. However, challenges should be faced to have a successful and a suitable formulation. The residence in the buccal environment should be carefully considered: the accidental swallowing of the delivery systems and the continuous dilution of the saliva could cause a low residence time and consequently a low drug bioavailability. Moreover, the contact between buccal mucosa and the drug delivery systems should be intimate, to allow the drug to act locally or to be absorbed [4, 5]. To go beyond these disadvantages, the drug delivery systems should be characterized by specific interaction with the buccal mucosa, to prevent the drug dispersion via the gastrointestinal system, and should be able to control the drug release and to assure a suitable concentration of the drug in the target tissue. Moreover, it should protect the drug from enzymatic degradation due to the presence saliva or microorganisms [2, 3].

There are data to suggest that up to 1 in 5 men and 1 in 10 women will develop at least one stone during their lifetime antibiotics for acne sun exposure arzomicin 100 mg fast delivery. The peak incidence occurs between the ages of 40 and 49 years and it is more common in men than women antibiotic resistance the last resort arzomicin 100 mg order with mastercard, with a ratio of 2 antibiotics for pneumonia arzomicin 500 mg buy. The prevalence and incidence rates are highest for Caucasians treatment for sinus infection in pregnancy purchase 250 mg arzomicin otc, followed by Hispanics antibiotic quiz nursing discount arzomicin 100 mg with visa, then people of African origin and Asians, in that order [3]. Cystinuria is a genetic cause of kidney stones with an average prevalence of 1 in 7000 births. Although cysteine stones are found in about 1% of stone formers, they represent a higher percentage of stones in children (about 5%). In addition to the costs associated with treatment of renal stones, this condition has a substantial economic impact since the individuals affected are often of working age. Once an individual has been diagnosed with nephrolithiasis, preventing a recurrence is essential. Urinary calcium phosphate and calcium oxalate gradually deposit on the plaques to create urinary calculus. Struvite stones, which are composed of magnesium ammonium phosphate, form only when urinary ammonia production is increased and the urine pH is persistently alkaline (>7. The first states that when urine has calcium and oxalate in a concentration more than that in which they can stay dissolved ­ that is, the urine is supersaturated with these elements ­ they combine to form a more stable and solid phase, a process called nucleation. In homogenous nucleation, similar ions join into crystals, whilst the more common heterogeneous nucleation results when crystals grow around dissimilar crystals or other substances in the urine, examples being calcium oxalate crystals nucleating around uric acid crystals or sloughed epithelial cells. Calcium phosphate precipitates in the basement membrane of the thin loops of Henle, erodes into the interstitium and then accumulates in the subepithelial space of the renal papilla. Patients with an increased susceptibility to urinary infection, such as those with neurogenic bladder or urinary diversion, also form pure struvite stones [1, 3]. In patients with mixed calcium and struvite stones, it is presumed that the primary event is calcium oxalate stone formation, with secondary infection and struvite deposition. A comprehensive medical evaluation should be performed to uncover the underlying metabolic defect(s) responsible for calcium stone formation [2]. Cystinuria is an inherited autosomalrecessive disease that is characterized by high concentrations of the amino acid cystine in urine, leading to the formation of cystine stones. The condition is characterized by decreased proximal tubular reabsorption of filtered cystine, resulting in increased urinary cystine excretion and cystine nephrolithiasis. Different Types of Renal Stones and Risk Factors Certain diseases and dietary habits can affect urine composition, which in turn influences the risk of nephrolithiasis. The universal risk factor is low urine output, due to either low fluid intake or high fluid losses, for example from sweating or gastrointestinal Renal Stones 55 Table 4. Proteus, Pseudomonas or Klebsiella) Cystinuria Calcium Stones Stones composed of calcium oxalate can occur in various disorders. In general, calcium phosphate stones are associated with the same risk factors as calcium oxalate stones (other than alkaline urine for the former and hyperoxaluria for the latter). Risk factors for developing calcium stones can be grouped under urinary factors, underlying medical conditions, dietary factors, and medications [5]. Urinary risk factors for developing renal calcium stones include: Higher urine calcium excretion, with or without hypercalcaemia. Higher urine oxalate excretion, which may be present in up to 40% of male and 15% of female stone formers and is a major risk factor for calcium oxalate stone formation. Marked hyperoxaluria may be Cysteine secondary to the increased intestinal absorption of oxalate (enteric oxaluria) or inherited enzymatic defects causing overproduction of oxalate (primary oxaluria). In patients with fat malabsorption, intestinal calcium binds to unabsorbed fatty acids, leaving oxalate free to be absorbed and then filtered by the kidney. Fat malabsorption leading to hyperoxaluria and renal stones may be seen in pancreatic insufficiency, inflammatory bowel disease, bowel resection, bariatric surgery, jejunoileal or gastric bypass surgeries. Primary hyperoxaluria: this is a rare autosomal recessive disorder that is characterized by enzymatic defects in glyoxylate metabolism, causing enhanced oxalate production with consequent calcium oxalate stone formation. Patients may present with unexplained cardiomyopathy or cardiac conduction defects, poor peripheral circulation and gangrene, joint pain, bone pain, spontaneous fractures, and diminished visual acuity. Liver transplantation is the only definitive therapy known, as that helps to replace the defective hepatic enzymes. Low urinary citrate, which may be seen in chronic metabolic acidosis predisposes to urinary calcium stones. Under normal conditions, citrate inhibits urinary calcium stone formation by binding with calcium to form a soluble complex, which is excreted in urine. The resultant low urinary citrate concentration can predispose to urinary calcium stone formation. Hyperuricosuria contributes to nephrolithiasis in 10­15% of calcium stones, as calcium oxalate crystals nucleate around uric acid crystals. Enteric oxaluria: fat malabsorption is the com- Underlying medical conditions that predispose to calcium stone formation include: Primary hyperparathyroidism, which is suspected because of the presence of hypercalcaemia that is often mild and intermittent [6]. It is estimated that this disorder is present in 12­20% of recurrent calcium stone formers [7]. The dietary risk factors for calcium stone formation include: A high animal protein diet, which can lead to increased urinary excretion of calcium and uric acid as well as decreased excretion of citrate. The exact contribution of dietary oxalate to urinary oxalate is controversial and likely varies considerably from person to person due to variable absorption. Lower calcium intake, which acts by increasing the intestinal absorption and subsequent urinary excretion of oxalate due to decreased calcium oxalate complex formation within the intestinal lumen [8]. The effect on oxalate more than counterbalances the decrease in calcium absorption and excretion. The following medications are associated with increased risk of calcium stone formation: Loop diuretics Corticosteroids Vitamin D/calcium supplements Theophylline Acetazolamide Amphotericin B Uric Acid Stones Uric acid stones result from persistently acidic urine (pH <5. Uric acid stones may antedate gouty arthritis in up to 40% of patients with primary gout. Renal Stones 57 In patients with chronic diarrhoea, ongoing bicarbonate loss (from the pancreatic secretions) and volume depletion lead to the kidneys trying to conserve sodium and water avidly. Bicarbonate loss in stool also leads to metabolic acidosis, which in turn leads to a compensatory increase in hydrogen secretion in urine. The net effect is concentrated and acidic urine that potentiates urate nephropathy. Apart from chronic metabolic acidosis, acidic urine may also be seen in patients with diabetes, insulin resistance, and obesity, possibly related to reduced ammoniagenesis [9]. Low urine volume due to inadequate fluid intake or excessive extrarenal fluid loss, as in diarrhoea or perspiration, can also lead to uric acid stones. The following medications, by increasing urinary uric acid concentration, are associated with an increased risk of uric acid stone formation: Patients should have 24hour urinary cystine excretion measured. Medications Precipitating as Renal Stones Urinary calculi can also be induced by medications when the drugs crystallize and become the primary component of the stones. Similar to the pathogenesis of calcium stones discussed earlier, urinary supersaturation of the agent may promote formation of the calculi. Drugs that induce calculi via this process include magnesium trisilicate, ciprofloxacin, sulphurcontaining medications such as sulfamethoxazoletrimethoprim, triamterene, indinavir, and ephedrine, alone or in combination with guaifenesin. Aspirin ­ high dosages (>3 g/day) can be uricosuric, whilst low dosages (1­2 g/day) cause uric acid retention Probenicid Allopurinol Other Risk Factors Other risk factors for developing renal stones include history of prior nephrolithiasis, family history of nephrolithiasis, obesity, and excessive physical exercise. Patients with hypertension have an approximately twofold higher risk of nephrolithiasis [10, 11]. Occasional patients present with large branched (staghorn) calculi filling the collecting system and requiring surgical management. Clinical Manifestations Occasionally, patients are diagnosed with asymptomatic nephrolithiasis when they undergo radiological imaging of the abdomen for other reasons or surveillance imaging due to a prior history of stones. This asymptomatic phase is more likely to continue in patients who do not have a history of renal colic [12]. Cystine Stones Patients with cystinuria have decreased proximal tubular reabsorption of filtered cystine, resulting in increased urinary cystine excretion and cystine nephrolithiasis. Usually patients present in childhood or young adulthood and rarely patients present with staghorn calculi requiring surgical management. The pattern of inheritance may be autosomal dominant or autosomal recessive with incomplete penetrance. Cystinuria is diagnosed amongst patients with nephrolithiasis and one or more of the following findings: Symptoms and Signs Symptoms develop when stones initially pass from the renal pelvis into the ureter. The most common symptom is pain, which varies from a mild ache to a severe pain requiring parenteral analgesics. The pain typically fluctuates in intensity and is related to movement of the stone in the ureter and associated ureteral spasm. Pain is thought to occur primarily from urinary obstruction with distention of the renal capsule, and the location of pain depends on the location of the obstruction. Obstruction in the upper ureter or renal pelvis causes flank pain or tenderness, whereas obstruction in the lower ureter leads to pain that Stone analysis showing cystine. Gross or microscopic haematuria occurs in the majority of patients with symptomatic (with pain) nephrolithiasis, and often in asymptomatic patients as well. Other than passage of a stone or gravel, this is the discriminating sign of a kidney stone in patients presenting with unilateral flank pain. However, the absence of haematuria in the setting of acute flank pain does not exclude nephrolithiasis. In approximately 10­30% of patients with documented nephrolithiasis, haematuria is not detected [13, 14]. The sensitivity of haematuria is thought to be dependent on the interval from the onset of acute pain to the time of urine examination ­ haematuria is more likely to be detected on the first day of onset of acute pain compared to subsequent days [15]. Other symptoms that are commonly seen in patients with nephrolithiasis include nausea, vomiting, dysuria, and urgency. Classic symptoms of nephrolithiasis are less common with struvite stones because of their smooth surface. The stone may grow rapidly over a period of weeks to months and, if not adequately treated, can develop into a staghorn or branched calculus involving the entire renal collecting system. Staghorn calculi, which are classified as upper urinary tract stones that involve the renal pelvis and extend into calyces, do not typically produce symptoms unless the stone is big enough to result in urinary tract obstruction or is associated with infection. They may lead to progressive renal impairment over time if present bilaterally [16]. A urine pH >7 is suggestive of calcium phosphate or struvite calculi, depending on the presence of phosphate or struvite crystals in the urine sediment. Although uric acid crystals and calcium oxalate crystals may be seen in individuals without nephrolithiasis, if seen in a patient with known stone disease they are likely to represent the composition of the stone. At least two sets of 24hour urine collections should be obtained to measure urine volume, pH and excretion of calcium, uric acid, citrate, oxalate, sodium, potassium, and creatinine (to ensure the completeness of the collection). Urine culture may show growth of urease producing organism such as Proteus, Pseudomonas or Klebsiella in those with struvite stones. Radiological Evaluation: NonContrast Computed Tomography of the Abdomen and Pelvis or Ultrasound the diagnosis of nephrolithiasis should be suspected in all patients with the acute onset of flank pain, particularly in the setting of haematuria and absent abdominal guarding. It is important to recognize that ureteral dilatation without a stone on the scan could represent recent passage of a stone. A plain abdominal Xray can detect sufficiently large radiopaque stones such as calcium, struvite, and cystine stones, but will miss radiolucent uric acid stones and may miss small stones or those overlying bony structures. Although struvite (magnesium ammonium phosphate) and cystine stones are often radiopaque, they are not as dense as stones composed of calcium oxalate or calcium phosphate. Struvite stones are more likely in the presence of large calculi in the renal pelvis, whereas the presence of nephrocalcinosis favours calcium phosphate stones. In general, calcium stones can usually be distinguished from uric acid, cystine, and struvite stones. Medical Expulsive Therapy the likelihood of spontaneous stone passage depends on the size and location of the stone; smaller and more distal stones are more likely to pass without intervention. Most stones less than 5 mm in diameter pass spontaneously, but stones greater than 10 mm in diameter are unlikely to do so [23]. Although studies directly comparing nifedipine with tamsulosin have reported similar rates of stone passage, a potential advantage of tamsulosin is somewhat faster stone passage and fewer hospitalizations and procedures. Management Acute Therapy Most patients with acute renal colic can be managed conservatively with analgesics. Forced intravenous hydration, compared with minimal intravenous hydration, does not appear to be more beneficial in reducing the amount of analgesics required or in facilitating stone passage [21]. Patients should be instructed to strain their urine for several days if possible and to bring in any stone that passes for analysis; this often enables clinicians to plan preventive therapy. In these settings, endoscopic stone fragmentation with a percutaneous or ureteroscopic approach is often preferred. However, there are data suggesting that a comprehensive medical evaluation is not costeffective for patients who have formed their first stone. Some therefore recommend only a limited evaluation after the first stone formation. Recommendations for Specific Stone Types Calcium Oxalate Risk factors for calcium oxalate stones include higher urine calcium, higher urine oxalate, and low urine citrate. High Urine Calcium Although the term hypercalciuria is used, there is no widely accepted cutoff level that distinguishes between normal and abnormal urine calcium excretion. Since the relation between urine calcium and stone risk appears to be continuous, the use of an arbitrary threshold should be avoided. Patients with persistent stone disease and high urine calcium that is not due to hypercalcaemia (often referred to as idiopathic hypercalciuria) should be managed with a reduced animal protein and low salt diet plus a thiazide diuretic [26]. Restriction in dietary calcium intake is not recommended unless the intake is excessive (more than 2000 mg/day). Although urine calcium excretion may decrease with restriction, the decrease in free intestinal calcium leads to decreased binding of oxalate by calcium in the intestinal lumen, resulting in increased absorption of dietary oxalate and enhanced oxalate excretion. The net effect may be increased supersaturation of the urine with calcium oxalate and an increased tendency to stone formation. Thiazide therapy can lower calcium excretion by as much as 50%, primarily by inducing mild volume depletion, which leads to a compensatory rise in the reabsorption of sodium in the thick ascending limb of loop of henle which in turn leads to a rise in passive calcium reabsorption.

The modification of the structure of the drug antibiotic resistance of staphylococcus aureus arzomicin 250 mg order with mastercard, the use of mucoadhesive materials non penicillin antibiotics for sinus infection order 250 mg arzomicin, permeation enhancers 999 bacteria order arzomicin on line, enzyme inhibitors and pH modifiers represent important strategies in this field [39 infection 6 months after hysterectomy arzomicin 500 mg order online, 53 viruswin32virutce arzomicin 100 mg purchase with amex, 55]. Other strategies used in oral mucosal delivery systems include photodynamic therapy, and the use of an external magnetic field or ultrasound [167, 177, 178]. The modification of the structure of the drug is considered an interesting strategy and could be performed using a prodrug or by adjusting the drug physical or chemical properties, including pH and solubility. The adjustment of the ionic state of a drug by increasing the non-ionized fraction during the penetration can promote its transcellular transport. However, the pH cannot exceed the range of the human oral tolerance, and the influence on the stability of the drug must be considered. Moreover, the addition of hydrophobic domains or incorporation of cyclodextrins have shown to solve the incompatibility between hydrophobic drugs and hydrophilic formulations, including hydrogels [39, 45, 53]. The increased interest in permeation enhancers have happened due to the ability to increase the absorption and, consequently, bioavailability of poorly soluble drugs, especially large hydrophilic molecules such as peptides [39, 54, 179]. An ideal permeation enhancers should be safe and effective, pharmacologically inactive, chemically inert, reversibly inert and prevent the permeability of pathological microorganisms [29, 35]. Most of the permeation enhancers have surfactant-like properties, and are classified according to their chemical or physical activity [39, 45, 53­55]. The most commonly known permeation enhancers are the bile salts, fatty acids and their salts and esters, azo compounds, complexing agents, surfactants, co-solvents and miscellaneous [53]. The bile salts or cholates are steroids with surfactant activity that promote both transcellular and paracellular permeation by denaturation of proteins, enzyme inactivation, solubilization and micellar entrapment, extraction of lipids or proteins from the cellular membrane, membrane fluidization and reverse membrane micellization [53, 55]. The cholates include sodium glycodeoxycholate, sodium taurodeoxycholate, sodium taurocholate, dihydroxy salt sodium deoxycolate [53, 55, 180]. The permeation enhancer properties of fatty acids and their salts and esters are dependent on the position of double bonds, isomer type (cis and trans), ionization state, chain length and degree of branching. For example, the unsaturation of oleic acid reduces lipid order and increases the fluidity in the oral mucosa. The most commonly known fatty acids are oleic acid, lauric acid and cod liver oil extract. The salts of fatty acids include sodium caprate and 100 Nanotechnology for oral drug delivery sodium laurate, whereas the esters are diethylene glycol, mono ethyl ether and glyceryl monostearate. Their mechanism relies on the inclusion of their structures in the cell membrane to change fluidity, dissolution of cholesterol and destabilize the cell membrane extraction of intercellular lipids [55, 180]. In fact, poly(acrylic acid) derivatives and chitosan are considered to be mucoadhesive polymers, but they can also act as permeation enhancers. Poly(acrylic acid) derivatives, such as polycarbophil and Carbopol 934P, can act as enzyme inhibitors [55]. Chitosan and its derivatives, in turn, can help the permeation of formulations, but their mechanism is not fully understood for the oral mucosa. Apparently, chitosan promotes the repackaging of the epithelium cells down to the basal membrane and partial disarrangement of desmosomes [55]. Moreover, the enlargement of the intercellular spaces was shown to be correlated to the disorganization of the lipid lamellae [55]. Surfactants are predominantly water-soluble and can form micelles in aqueous solutions with similar mechanisms to those of bile salts, and include sodium dodecyl (lauryl) sulfate, polysorbates, the laureths, Brijs and benzalkonium chloride. Sodium dodecyl sulfate is known to increase the drug absorption, but can damage the mucosa [55, 180]. Ethanol and propylene glycol are co-solvents that can change drug absorption by changing its thermodynamic activity, enhancing the concentration and facilitating its partition into the membrane, thereby promoting its passive diffusion [180]. Other permeation enhancer is lecithin (phosphatidylcholine), a phospholipid isolated from egg yolk or soybeans, which has been used to increase the absorption of insulin in vivo [180]. Other strategies regarding the excipients of the formulations include the incorporation of enzyme inhibitors and pH modifiers. Enzyme inhibitors are molecules capable of protecting the drug from enzymatic degradation, by degrading proteins or protease inhibitors [180]. The protease inhibitors described in the literature include aprotinin, puromycin, glutathione and bestatin [180]. The mechanisms of the inhibitors are dependent on the type of molecule and generally involve the stabilization of the macromolecular structure, formation of micelles or direct inhibition of the degrading enzymes. The derivatives of acrylic acid can be considered enzyme inhibitors as well [55, 180]. On the other hand, pH modifiers can change the pH of the saliva before the drug administration and increase the absorption through mucosal membranes. Therefore, unionized drugs can be absorbed on the surface of the membrane but, also in deeper layers, where the pH may change the ionization and drug absorption [180]. The efficiency of oral mucosal drug delivery systems can be improved by using external agents like electrical current, ultrasounds or an external magnetic field. The electrical Mucoadhesive and mucus-penetrating polymers for drug delivery 101 current can be applied by iontophoresis, where a flow of ionic hydrophilic molecules is generated. This is considered as a physical permeation technique for small molecules and biologics [55, 179]. Ultrasounds are sound waves higher than the range of human hearing (>20 kHz), used for lithotripsy, liposuction, imaging and tumor ablation, for example. Particularly, low-frequency ultrasounds (100 kHz) can lead to the occurrence of transient cavitation, where micron-scale bubbles are nucleated and collapsed, creating a jet fluid carrier of therapeutics into the tissue cavity, and providing increased therapeutic efficacy. France and co-authors developed a device with a drug reservoir that could be applied in the mouth by the use of ultrasound [176]. The authors demonstrated the effectiveness of the device for depositing a wide range (3­500 kDa) of dextrans into the tissue, and proved the efficacy of budesonide in inflammatory lesions models [176]. The application of an external magnetic field in formulations containing iron oxide magnetic nanoparticles has shown diverse applications, including cellular therapy, tissue repair, sensor for metabolites and other biomolecules, in vitro separation and drug targeting [177]. The external magnetic field can cause local hyperthermia, an important strategy in the treatment of several diseases. Toledo and co-authors developed magnetic nanoparticles as carriers to be administered in periodontal diseases [177]. Diverse dyes have been studied against caries microorganisms including methylene blue, phtalocyanine, porphyrin, rose Bengal, erythrosine, ortho-toluidine blue. These methods have been reported to affect the mucoadhesive properties of formulations, mainly for solid dosage forms [47]. This section discusses the technologies involved in the development of films, nanofibers, wafers and micro/ nanoparticles. Pharmaceutical films are mainly prepared by solvent casting and hot-melt extrusion, but also by compression and inkjet printing [10, 47, 51, 53, 55, 179]. The most widely used technique to prepare films is the solvent casting method, for being an inexpensive process, easy to process, and that can be prepared with small and large molecules, promoting flexibility of the layer containing the drug. Firstly, the casting dispersion should be prepared with a mucoadhesive polymer, with or without plasticizer, in a solvent or 102 Nanotechnology for oral drug delivery solvent mixture in which the drug should be incorporated. However, air bubble removal is a critical step, since aerated films can lead to the production of films with heterogeneous thicknesses. Moreover, the rheological properties of the solution can influence the drying rates, film thickness, content uniformity and physical surface of films [10, 47, 51]. Other techniques have been employed to prepare these dosage forms, including direct compression and hot-melt extrusion, which does not use organic solvents and proves to be environmentally friendly [10, 44, 53]. Alternatively, hot-melt extrusion technology provides energy saving, shorter and efficient processing due to its continuous production process, and higher drug delivery efficiency and permeability performance. This technology is based in the melting process of diverse excipients and small molecules to form crosslinks between the molecules. The heat exposure during extrusion is harmful to biologic-loaded matrices such as proteins and enzymes, which could be degraded. The use of plasticizers in the optimization of the extrusion process has demonstrated to allow the formation of polymeric matrices with biologics and macromolecules [10, 53, 179]. The inkjet printing technology has also been used to produce drug-loaded buccal films and has demonstrated diverse benefits. It allows the production of personalized dosage forms, and solves the dose limitation issue by optimizing the printing process, using droplet formation mechanisms in inkjet cartridges [179]. Nanofibers, commonly prepared by electrospinning, are obtained by the high electrostatic field applied in a liquid containing the polymer solution or polymer melt and the drug. This technology of manufacturing enables the production of unique structures that cannot be produced by other conventional manufacturing techniques. Electrospinning can be used to tune the physical structure and biological functionality of the material. Such technique requires a pump that drives the liquid sample by a metal nozzle of a syringe through an electrical field from a source of high electric voltage. This electric field promotes the deformation of the sample and the formation of a charged fluid stream that elongates, and results in the formation of continuous solid nanofibers, due to the evaporation of solvent. The methodology of drug incorporation in these structures is dependent on the drug characteristics and it should be optimized to achieve the desired drug-release kinetics. Therefore, the drug can be either dispersed in the polymer solution before the electrospinning or coated on the nanofiber surface by physical or chemical bound [181­183]. Moreover, the desired properties could be tailored by working with the parameters of the preparation process (distance between nozzle and screen, voltage applied, flow of polymer solution/melt), environmental conditions (temperature, relative humidity), and the polymer solution (solvent, polymer and excipient). The appropriate combination of the mentioned variables can control the fiber diameter, porosity and thickness [181]. Mucoadhesive and mucus-penetrating polymers for drug delivery 103 Patches can be prepared by diverse technologies including electrospinning and the deposition of a backing layer by 3D printing [183], spray-drying and freeze-drying techniques. Improved drug release and permeation performance can be achieved by spraydrying and compression when compared to conventional mixing patch compression with auxiliary powder. For instance, differential thermal analysis data has shown that, after spray drying and cross-link with other excipients, the drug was present in the formulations in an amorphous form, which can explain the improved performance of release and permeation [53]. This technique allows the development of formulations with improved stability of final products with high porosity (gain loading capacity per weight). The magnetic stirrers or mechanical stirrers are used in laboratory scale, whereas a temperature-controlled tank and mechanical agitation are necessary for industrial scale. The freezing step determines the shape of the wafers, as well as their surface topology and porosity. Additionally, the freeze-drying or lyophilization of gels promotes the removal of water of the frozen matrix due to vacuum sublimation [184]. The parameters involved in freezing of sample include target temperature, rate and intermediate thermal, and are critical procedures for obtaining the wafers. In this way, fast rates lead to smaller particles and more formation of crystals, which need longer drying periods to achieve complete dryness. While slow freezing results in the formation of larger crystals, some thermal treatments can promote homogeneity and reduced drying rates. Nucleation is a recent innovation that can be used to control the ice crystals upon freezing. When nucleation is simultaneously induced by depressurization, ice fog and temperature quench freezing, it can increase homogeneity of the ice crystals. Micro/nanoparticles are classified into different classes based on their properties. They can be polymeric, lipidic and magnetic, among others, and consequently, their composition greatly influences the technology chosen to prepare them. Considering polymeric micro/nanoparticles, diverse techniques have been reported in the literature, such as cross-linking techniques, chemical cross-linking, drying techniques, reverse micellar method, emulsification solvent evaporation and nanoprecipitation [186]. In this way, the ionic cross-linking agent is dropped under stirring or sonication, and no organic solvent or chemical reaction is required. On the other hand, complex coacervation is a liquid-liquid process, in which two ionic solutions form an ionic complex, and are separated by washes, filtration or centrifugation. The chemical crosslinking technique promotes a chemical interaction between chemical groups. Once the cross-linking agents (ascorbyl palmitate or glutaraldehyde, for instance) are incorporated in a water-oil emulsion containing an aqueous phase (polymer and drug) and an external immiscible solvent, the particles can be separated and washed. Diverse drying 104 Nanotechnology for oral drug delivery techniques have been reported to prepare polymeric micro/nanoparticles including natural air-drying, freeze-drying, microwave, spray-drying and supercritical drying. The spray-drying consists in the atomization of the complex liquid mixture (drug and excipients in an organic or aqueous polymer solution). When the liquids get in contact with the hot air, the droplets are dried, and the micro/nanoparticles are produced [186]. Supercritical drying is a technique based on a mixture of a supercritical agent (carbon dioxide or nitrous oxide), a liquid dispersion of polymers, and a drug, forming a homogenous phase. The dryness and subsequent formation of the particulate systems occur under controlled conditions of pressure and temperature. In the reverse micellar preparation, a surfactant is dispersed in a non-polar solvent and micelles as aqueous droplets are formed at certain compositions of water-in-oil emulsion. The emulsification and solvent evaporation technology is based on the use of a volatile solvent. The system is emulsified, stirred until the evaporation of the solvent, and the micro/nanoparticles are separated by filtration or centrifugation [187, 188]. Finally, the nanoprecipitation occurs by the preparation of a solution containing the solvent. Once the two phases are mixed, the polymer precipitates and encapsulates the drug [189]. Diverse methods have been described for iron magnetic nanoparticles, involving aqueous and organic phases such as aerosol/vapor, sonolysis, electrochemical, flow injection, sol-gel reactions, polyol method, synthesis under constrained environment, hydrothermal, and high temperatures. Sol-gel technique is performed in a wet environment, where solutions of precursors and their chemical reactions produce nanoparticles in "sol" medium. Laser ablation technique produces nanosystems by a pulsed laser source (532 nm) at 100 kHz repetition rate for 15 min. The coprecipitation technique is based on aqueous solutions containing ferric/ ferrous ions, which are incorporated in base solutions, and precipitate to generate magnetic iron oxides [177].

The state of Florida mandates that anesthesiologists referred for opiate disorders are contractually required to use naltrexone for 2 years infection kongregate generic 500 mg arzomicin overnight delivery. In a small prospective study antibiotic zeniquin order arzomicin on line, 11 anesthesiologists treated with naltrexone were compared with 11 controls: only one individual in the naltrexone program relapsed while 8 of 11 (72%) in the untreated group relapsed antibiotics for uti nausea purchase arzomicin 500 mg visa. Those on naltrexone also had higher rates of return to the practice of anesthesiology bacteria use restriction enzymes to quizlet 100 mg arzomicin purchase. In a review of outcomes for residents treated for chemical dependency antibiotics for sinus infection dose buy generic arzomicin 100 mg line, most program directors (80%) had at least one impaired trainee and 19% reported a pretreatment fatality. Despite these statistics, 43% believed that residents should be allowed to continue their training. Bryson and Levine conducted an intensive 12-month posttreatment program involving an anesthesia simulator followed by gradual reintroduction to the clinical practice of anesthesia. Two of those individuals remained in recovery at 3 and 6 years, whereas one relapsed at 9 years. The decision whether to return or retrain is difficult, and circumstances vary on an individual basis. Residents often do not have the social and financial supports of graduated physicians, and they are exposed to the substances of risk for perhaps 40 more years. Fatigue Excessive tiredness due to inadequate sleep, physical illness, or other causes can result in fatigue. In general, physicians are not able to compensate for loss of sleep or to recover from illnesses because of the requirements of their work environment to patient care issues or work structures. Fatigue may place patients at risk of injury, as well as impact the health and safety of anesthesiologists. Fatigue in trainees became a public concern with a case involving Libby Zion, a young woman whose unfortunate death was determined in court to be related to 36-hour duty periods worked by the physicians providing her care. Physicians should understand the causes of fatigue, the impact on patients and themselves, and the means to manage the challenges ever present in a difficult and unpredictable work environment. Extended work duration of interns is associated with increases in percutaneous injuries. Depression, fatigue, and sleepiness were associated with a higher likelihood of a motor vehicle incident in resident physicians. A study of 149 residentphysicians at five academic medical centers revealed that many residents perceived that sleep loss and fatigue had a major impact on their personal lives such that personal and social activities were deferred or postponed. The benefit of limitation of duty hours is unclear, and negative consequences on patient care and education may result. Early studies of the impact of duty hour restrictions demonstrated that when efforts were made to reduce sleep deprivation, medical errors were lower, as were patient hospital length of stay and laboratory tests ordered,197 but this has not been a consistent finding, and the relationship between duty hour restrictions and quality of care remains controversial. Ahmed and associates performed a systematic review of the effects of duty hour restrictions in surgery. Their review found that wellness improved, and fatigue and burnout declined after implementation of the 2003 guidelines but further improvements were not seen after the 2011 modifications. Written examination scores were unchanged, but passage of oral examinations decreased in surgery. Programs are also required to ensure adequate sleep facilities and safe transportation options after duty. At their core, the restrictions included an 80-hour weekly duty limit, 10 hours of rest between shifts, and no more than 24 hours of continuous duty with a limit of 6 hours for transition of care and education. Policymakers are urged to consider relevant aspects of sleep physiology that affect performance. Theodora Nicholau for her contribution to this chapter in the prior edition of this work. Criteria for a Recommended Standard: Occupational Exposure to Anesthetic Gases and Vapors; 1977. Occupational safety and health standards: Toxic and hazardous substances, ionizing radiation. Medical Review Officer Guidance Manual for Federal Workplace Drug Testing Programs. Occupational chronic sevoflurane exposure in the everyday reality of the anesthesia workplace. Does occupational exposure to anesthetic gases lead to increase of pro-inflammatory cytokines Exposure to sevoflurane and nitrous oxide during four different methods of anesthetic induction. Psychomotor performance following exposure to trace concentrations of inhalation anesthetics. The acute and residual effects of subanesthetic concentrations of isoflurane/nitrous oxide combinations on cognitive and psychomotor performance in healthy volunteers. The effects of subanesthetic concentrations of sevoflurane and nitrous oxide, alone and in combination, on analgesia, mood, and psychomotor performance in healthy volunteers. Within-subject comparison of the subjective and psychomotor effects of a gaseous anesthetic and two volatile anesthetics in healthy volunteers. Anaesthetic practice and pregnancy: controlled survey of male anaesthetists in the United Kingdom. Exposure to anaesthetic gases and spontaneous abortion: response bias in a postal questionnaire study. Risk of spontaneous abortion in women occupationally exposed to anaesthetic gases: a meta-analysis. Task force on trace anesthetic gases; committee on occupational health of operating room personnel. Exposure to anesthetic gases and congenital anomalies in offspring of female registered nurses. Szyfter K, Stachecki I, Kostrzewska-Poczekaj M, Szaumkessel M, Szyfter-Harris J, Sobczyski P. A longitudinal study for investigating the exposure level of anesthetics that impairs neurobehavioral performance. A follow-up study on occupational exposure to inhaled anaesthetics in Eastern European surgeons and circulating nurses. Evaluation of radiation exposure pattern and radiation absorbed dose resulting from occupational exposure of anesthesiologists to ionizing radiation. Occupational Safety and Health Standards: Toxic and Hazardous Substances, Ionizing Radiation. Influence of standing positions and beam projections on effective dose and eye lens dose of anaesthetists in interventional procedures. Radiation exposure of operators performing transesophageal echocardiography during percutaneous structural cardiac interventions. The neurointerventional procedure room of the future: predicting likely innovations in design and function. Application of a two-zone model to estimate medical laser-generated particulate matter exposures. A pilot study to determine medical laser generated air contaminant emission rates for a simulated surgical procedure. Health risks associated with exposure to surgical smoke for surgeons and operation room personnel. Experimental study of the potential hazards of surgical smoke from powered instruments. Protecting staff against airborne viral particles: in vivo efficiency of laser masks. Improving hand hygiene compliance in the anesthesia working room work area: more than just more hand rubs. Frequency of interactions and hand disinfections among anesthesiologists while providing anesthesia care in the operating room: induction versus maintenance. Comparison of compliance of glove use among anesthesia providers: a prospective blinded observational study. Guidelines for preventing the transmission of mycobacterium tuberculosis in health-care settings, 2005. Blood and body fluid exposure risks among health care workers: results from the duke health and safety surveillance system. Extended work duration and the risk of self-reported percutaneous injuries in interns. Evaluation of blunt suture needles in preventing percutaneous injuries among healthcare workers during gynecologic surgical procedures-New York City, March 1993-June 1994. Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Iatrogenic streptococcus salivarius meningitis after spinal anaesthesia: need for strict application of standard precautions. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. Aerosol dispersion during various respiratory therapies: a risk assessment model of nosocomial infection to health care workers. Health care worker follow-up compliance after occupational bloodborne pathogens exposure: a brief report. Occupational exposure to bloodborne pathogens; needlestick and other sharps injuries; final rule. Multiple clusters of hepatitis virus infections associated with anesthesia for outpatient endoscopy procedures. Guideline for disinfection and sterilization of prioncontaminated medical instruments. Success of reentry into anesthesiology training programs by residents with a history of substance abuse. Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention. Substance abuse: a national survey of Canadian residency program directors and site chiefs at university-affiliated anesthesia departments. Clinical and demographic profile of anesthesiologists using alcohol and other drugs under treatment in a pioneering program in Brazil. Substance use disorder amongst Australian and New Zealand anaesthetic trainees: an analysis of 30 years of data. Comparative abuse liability of intravenously administered remifentanil and fentanyl. Intranasal self-administration of remifentanil as the foray into opioid abuse by an anesthesia resident. Risk factors for relapse in health care professionals with substance use disorders. Risk and outcomes of substance use disorder among anesthesiology residents: a matched cohort analysis. Psychoactive substance use among American anesthesiologists: a 30-year retrospective study. Development of a scheduled drug diversion surveillance system based on an analysis of atypical drug transactions. Validation of a system to detect scheduled drug diversion by anesthesia care providers. Random drug testing to reduce the incidence of addiction in anesthesia residents: preliminary results from one program. Drug testing physicians for substances of abuse: case report of a false-positive result. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention Division of Workplace Programs. Anesthesiologists with substance use disorders: a 5-Year outcome study from 16 state physician health programs. Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice. Chemical dependency treatment outcomes of residents in anesthesiology: results of a survey. Should anesthesia residents with a history of substance abuse be allowed to continue training in clinical anesthesia One approach to the return to residency for anesthesia residents recovering from opioid addiction. Association of resident fatigue and distress with occupational blood and body fluid exposures and motor vehicle accidents. The effects of sleep loss and fatigue on resident-physicians: a multi-institutional mixedmethod study. Effect of a change in house staff work schedule on resource utilization and patient care. A systematic review of the effects of resident duty hour restrictions in surgery: impact on resident wellness, training, and patient outcomes. Joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society on the recommendation of sleep for a healthy adult: methodology and discussion. Resident workload, conference attendance, duty hour compliance, and patient safety. Investigators are constrained by the need to draw conclusions based on a sample of patients, providers, or systems rather than the whole of the population of interest, and this introduces random, systematic, and design error that threatens internal and external validity. Observational (or nonexperimental) studies involve allowing nature or clinical care to take its course, without any major modification due to study-related procedures. However, nonexperimental designs are prone to systematic error, such as selection and information bias. In experimental studies the investigators do not let nature (or clinical care) take its course, but actively intervene to test a new intervention. Randomization and blinding reduce the risk of random and systematic errors in experimental studies, but generalizability can be limited.

Arzomicin 250 mg buy on line. Versafit Commercial Gym Flooring.

References